Cardiff Oncology (CRDF) stock

Worth $61.8MShares as of Aug 6

$0.79

-0.74%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score CRDF. It is priced too low for a fair Quality Score.

Healthcare · Biotech

NextQ1 2027“period for Cardiff as we prepare to initiate our registrational Phase 3 study in the first quarter of 2027.”Trial start · SEC filing · Oct 27

Cash$34.5M, about 3 quarters at the last year's spendingOn Jun 30 · raised money since, not counted · the company says “into the third quarter of 2027”

Follow CRDF's trial news. Pro members can get an alert when Cardiff Oncology files news, and see its trials, share raises, and its CEO's filings.

Get an alert when CRDF files news on its trialSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$34.5M, about 3 quarters at the last year's spendingOn Jun 30 · raised money since, not counted · the company says “into the third quarter of 2027”

What's next for CRDF, and how long its cash lasts

Next step the company has named

Q1 2027“period for Cardiff as we prepare to initiate our registrational Phase 3 study in the first quarter of 2027.”Trial start · SEC filing · Oct 27

What it means: when a trial begins, or reaches the stage the company named.

A trial underway: Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationPhase 2 · Active · 110 people · main data estimated Nov 2026 · NCT06106308

For Pro members: 32 filings.

Cash runway Jun 30 balance sheet

About 3 quarters

$34.5M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into the third quarter of 2027” (8-K, Aug 11). It has raised money since that balance sheet, which is not counted here.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Feb 27, 2025)
At-the-market share sales program (S-3, filed Feb 27, 2025)

For Pro members: 2 raises and their amounts, and the share count against a year ago.

Insiders

Director Gary W Pace bought 687,285 shares on Jul 14. 3 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when Mani Mohindru buys or sells

For Pro members: every trade, and Mani Mohindru’s 12 filings and quotes.

Get an alert when CRDF files news on its trialA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

CRDF's latest filings

A new insider's holdings3, filed Oct 27
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer8-K, filed Oct 27
Quarterly report10-Q, filed Aug 11

25 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why CRDF isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. CRDF trades at $0.79. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.